Exicure, Inc. (XCUR) stock
XCURNasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.04−0.04 (-3.70%)
Close on Nov 18, 2026Market cap $6.81MP/E –Yield –
Exicure cash
Cash and short-term investments held at the end of each period.
Exicure's cash was $1.72M at Jun 30, 2026. For fiscal 2025 it was $3.75M, down 70.1% from the year before. Over ten years it grew -14.9% a year on average. The highest annual figure on record is $110.79M in fiscal 2019.
Annual cash
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $3.75M | -70.1% |
| FY2024 | Dec 31, 2024 | $12.51M | +520.4% |
| FY2023 | Dec 31, 2023 | $2.02M | -79.4% |
| FY2022 | Dec 31, 2022 | $9.78M | -79.8% |
| FY2021 | Dec 31, 2021 | $48.34M | -42.0% |
| FY2020 | Dec 31, 2020 | $83.28M | -24.8% |
| FY2019 | Dec 31, 2019 | $110.79M | +321.8% |
| FY2018 | Dec 31, 2018 | $26.27M | +2.0% |
| FY2017 | Dec 31, 2017 | $25.76M | +31.3% |
| FY2016 | Dec 31, 2016 | $19.62M | +4.8% |
| FY2015 | Dec 31, 2015 | $18.73M | – |
Quarterly cash
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $1.72M | -78.1% |
| Q1 FY2026 | Mar 31, 2026 | $2.60M | -75.0% |
| Q4 FY2025 | Dec 31, 2025 | $3.75M | -70.1% |
| Q3 FY2025 | Sep 30, 2025 | $4.44M | +366.7% |
| Q2 FY2025 | Jun 30, 2025 | $7.86M | +461.3% |
| Q1 FY2025 | Mar 31, 2025 | $10.42M | +565.4% |
| Q4 FY2024 | Dec 31, 2024 | $12.51M | +520.4% |
| Q3 FY2024 | Sep 30, 2024 | $951.00K | -55.2% |
| Q2 FY2024 | Jun 30, 2024 | $1.40M | -60.4% |
| Q1 FY2024 | Mar 31, 2024 | $1.57M | -86.0% |
| Q4 FY2023 | Dec 31, 2023 | $2.02M | -79.4% |
| Q3 FY2023 | Sep 30, 2023 | $2.12M | -87.4% |
| Q2 FY2023 | Jun 30, 2023 | $3.54M | -84.9% |
| Q1 FY2023 | Mar 31, 2023 | $11.16M | -59.5% |
| Q4 FY2022 | Dec 31, 2022 | $9.78M | -79.8% |
| Q3 FY2022 | Sep 30, 2022 | $16.85M | -72.8% |
| Q2 FY2022 | Jun 30, 2022 | $23.40M | -59.1% |
| Q1 FY2022 | Mar 31, 2022 | $27.58M | -59.8% |
| Q4 FY2021 | Dec 31, 2021 | $48.34M | -42.0% |
| Q3 FY2021 | Sep 30, 2021 | $62.04M | -34.9% |
| Q2 FY2021 | Jun 30, 2021 | $57.26M | -34.2% |
| Q1 FY2021 | Mar 31, 2021 | $68.64M | -31.4% |
| Q4 FY2020 | Dec 31, 2020 | $83.28M | -24.8% |
| Q3 FY2020 | Sep 30, 2020 | $95.28M | +35.4% |
| Q2 FY2020 | Jun 30, 2020 | $86.98M | +406.4% |
| Q1 FY2020 | Mar 31, 2020 | $100.00M | +350.5% |
| Q4 FY2019 | Dec 31, 2019 | $110.79M | +321.8% |
| Q3 FY2019 | Sep 30, 2019 | $70.39M | +117.0% |
| Q2 FY2019 | Jun 30, 2019 | $17.18M | +4.9% |
| Q1 FY2019 | Mar 31, 2019 | $22.20M | +5.1% |
| Q4 FY2018 | Dec 31, 2018 | $26.27M | +2.0% |
| Q3 FY2018 | Sep 30, 2018 | $32.45M | +41.5% |
| Q2 FY2018 | Jun 30, 2018 | $16.38M | +1060094.2% |
| Q1 FY2018 | Mar 31, 2018 | $21.12M | +293574.4% |
| Q4 FY2017 | Dec 31, 2017 | $25.76M | +31.3% |
| Q3 FY2017 | Sep 30, 2017 | $22.94M | +63.0% |
| Q2 FY2017 | Aug 31, 2017 | $1.55K | – |
| Q1 FY2017 | May 31, 2017 | $7.19K | – |
| Q4 FY2016 | Dec 31, 2016 | $19.62M | – |
| Q3 FY2016 | Sep 30, 2016 | $14.07M | – |
See a number that looks wrong?